COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2264: Articles 22631-22640  | Next

Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2
Bhattacharya, D. D., Parai, D. D., Rout, U. K., Nanda, R. R., Kanungo, D. S., Dash, D. G. C., Palo, D. S. K., Giri, D. S., Choudhary, H. R., Kshatri, D. J. S., Turuk, D. J., Mishra, D. B., Dash, D. S., Pati, D. S.
10.1101/2020.09.11.20192591 — Posted: 2020-09-11
Relationship between nursing home COVID-19 outbreaks and staff neighborhood characteristics
Shen, K.
10.1101/2020.09.10.20192203 — Posted: 2020-09-11
Retrospective study of COVID-19 seroprevalence among tissue donors at the onset of the outbreak before implementation of strict lockdown measures in France
Germain, N., Herwegh, S., Hatzfeld, A. S., Bocket, L., Prevost, B., Danze, P. M., Marchetti, P.
10.1101/2020.09.11.20192518 — Posted: 2020-09-11
Lessons from the COVID-19 pandemic: People's experiences and satisfaction with telehealth during the COVID-19 pandemic in Australia
Isautier, J. M., Copp, T., Ayre, J., Cvejic, E., Meyerowitz-Katz, G., Batcup, C., Bonner, C., Dodd, R., Nickel, B., Pickles, K., Cornell, S., Dakin, T., McCaffery, K. J.
10.1101/2020.09.10.20192336 — Posted: 2020-09-11
Early effect of the Covid-19 epidemic on vaccine coverage of major antigens in Guinea: an analysis of the interrupted time series of national immunization coverage
Dabo, M., YOMBOUNO, S., KANDE, M., SOMPARE, D., Camara, A., Bah, M. D., Solano, S., LATOU, F., Balde, I., Sylla, Y., Conde, I. s., Kuotou, G. C., TOURE, A. A., Magassouba, A. S.
10.1101/2020.09.11.20192161 — Posted: 2020-09-11
COVID-19: Mechanistic model calibration subject to active and varying non-pharmaceutical interventions
Willis, M. J., Wright, A. R., Bramfitt, V., Grisales Diaz, V. H.
10.1101/2020.09.10.20191817 — Posted: 2020-09-11
No association between circulating levels of testosterone and sex hormone-binding globulin and risk of COVID-19 mortality in UK biobank
Fan, X., Yang, J., Wang, J., Yin, C., Zhu, M., Ma, H., Jin, G., Hu, Z., Shen, H., Hang, D.
10.1101/2020.09.11.20191783 — Posted: 2020-09-11
SARS-CoV-2 Antibody Prevalence and Association with Routine Laboratory Values in a Life Insurance Applicant Population
Rigatti, S. J., Stout, R.
10.1101/2020.09.09.20191296 — Posted: 2020-09-11
Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to SARS-CoV-2 severity
Richardson, T. G., Fang, S., Mitchell, R. E., Holmes, M. V., Davey Smith, G.
10.1101/2020.09.10.20191932 — Posted: 2020-09-11
Increased extravascular lung water index (EVLWI) reflects rapid inflammatory oedema and mortality in COVID-19 associated ARDS
Rasch, S., Schmidle, P., Sancak, S., Herner, A., Huberle, C., Schulz, D., Mayr, U., Schneider, J., Spinner, C., Geisler, F., Schmid, R. M., Lahmer, T., Huber, W.
10.1101/2020.09.11.20192526 — Posted: 2020-09-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).